238 related articles for article (PubMed ID: 31746553)
1. Effects of Liraglutide and Behavioral Weight Loss on Food Cravings, Eating Behaviors, and Eating Disorder Psychopathology.
Chao AM; Wadden TA; Walsh OA; Gruber KA; Alamuddin N; Berkowitz RI; Tronieri JS
Obesity (Silver Spring); 2019 Dec; 27(12):2005-2010. PubMed ID: 31746553
[TBL] [Abstract][Full Text] [Related]
2. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial.
Tronieri JS; Wadden TA; Walsh O; Berkowitz RI; Alamuddin N; Gruber K; Leonard S; Bakizada ZM; Chao AM
Int J Obes (Lond); 2020 Feb; 44(2):353-361. PubMed ID: 30926955
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial.
Wadden TA; Tronieri JS; Sugimoto D; Lund MT; Auerbach P; Jensen C; Rubino D
Obesity (Silver Spring); 2020 Mar; 28(3):529-536. PubMed ID: 32090517
[TBL] [Abstract][Full Text] [Related]
4. Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial.
Wadden TA; Walsh OA; Berkowitz RI; Chao AM; Alamuddin N; Gruber K; Leonard S; Mugler K; Bakizada Z; Tronieri JS
Obesity (Silver Spring); 2019 Jan; 27(1):75-86. PubMed ID: 30421856
[TBL] [Abstract][Full Text] [Related]
5. Changes in health-related quality of life with intensive behavioural therapy combined with liraglutide 3.0 mg per day.
Chao AM; Wadden TA; Walsh OA; Gruber KA; Alamuddin N; Berkowitz RI; Tronieri JS
Clin Obes; 2019 Dec; 9(6):e12340. PubMed ID: 31691531
[TBL] [Abstract][Full Text] [Related]
6. Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.
Tronieri JS; Fabricatore AN; Wadden TA; Auerbach P; Endahl L; Sugimoto D; Rubino D
Obes Facts; 2020; 13(6):572-583. PubMed ID: 33197917
[TBL] [Abstract][Full Text] [Related]
7. Measures of adherence as predictors of early and total weight loss with intensive behavioral therapy for obesity combined with liraglutide 3.0 mg.
Tronieri JS; Wadden TA; Walsh O; Berkowitz RI; Alamuddin N; Chao AM
Behav Res Ther; 2020 Aug; 131():103639. PubMed ID: 32450367
[TBL] [Abstract][Full Text] [Related]
8. Treatment of binge eating disorder.
Wilson GT
Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
[TBL] [Abstract][Full Text] [Related]
9. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as.
Grilo CM; White MA
Behav Res Ther; 2013 Mar; 51(3):167-75. PubMed ID: 23376451
[TBL] [Abstract][Full Text] [Related]
10. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial.
Tronieri JS; Wadden TA; Walsh OA; Berkowitz RI; Alamuddin N; Gruber K; Leonard S; Chao AM
Metabolism; 2019 Jul; 96():83-91. PubMed ID: 30902750
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of lorcaserin and lifestyle counselling for weight loss maintenance: changes in emotion- and stress-related eating, food cravings and appetite.
Chao AM; Wadden TA; Pearl RL; Alamuddin N; Leonard SM; Bakizada ZM; Pinkasavage E; Gruber KA; Walsh OA; Berkowitz RI; Alfaris N; Tronieri JS
Clin Obes; 2018 Dec; 8(6):383-390. PubMed ID: 30222916
[TBL] [Abstract][Full Text] [Related]
12. The Current Role of Liraglutide in the Pharmacotherapy of Obesity.
Christou GA; Katsiki N; Kiortsis DN
Curr Vasc Pharmacol; 2016; 14(2):201-7. PubMed ID: 26074046
[TBL] [Abstract][Full Text] [Related]
13. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.
Jensterle M; Kocjan T; Kravos NA; Pfeifer M; Janez A
Endocr Res; 2015; 40(3):133-8. PubMed ID: 25330463
[TBL] [Abstract][Full Text] [Related]
14. Food cravings, binge eating, and eating disorder psychopathology: Exploring the moderating roles of gender and race.
Chao AM; Grilo CM; Sinha R
Eat Behav; 2016 Apr; 21():41-7. PubMed ID: 26741258
[TBL] [Abstract][Full Text] [Related]
15. Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies.
Farr OM; Upadhyay J; Rutagengwa C; DiPrisco B; Ranta Z; Adra A; Bapatla N; Douglas VP; Douglas KAA; Nolen-Doerr E; Mathew H; Mantzoros CS
Diabetes Obes Metab; 2019 Nov; 21(11):2459-2464. PubMed ID: 31282006
[TBL] [Abstract][Full Text] [Related]
16. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
Lundgren JR; Janus C; Jensen SBK; Juhl CR; Olsen LM; Christensen RM; Svane MS; Bandholm T; Bojsen-Møller KN; Blond MB; Jensen JB; Stallknecht BM; Holst JJ; Madsbad S; Torekov SS
N Engl J Med; 2021 May; 384(18):1719-1730. PubMed ID: 33951361
[TBL] [Abstract][Full Text] [Related]
17. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
Jensterle M; Kravos NA; Pfeifer M; Kocjan T; Janez A
Hormones (Athens); 2015; 14(1):81-90. PubMed ID: 25885106
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacotherapy for obesity].
Bruun JM
Ugeskr Laeger; 2016 Oct; 178(44):. PubMed ID: 27808050
[TBL] [Abstract][Full Text] [Related]
19. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
